Simon Snicker

Saw Jordan Peterson at one of those inauguration balls. His eyes are sleepy. Looked doped up tbh. Felt bad as he was giving a speech and nobody was listening. Take away their glam squad, hair and make-up, and fake lighting in studio, and most of these guys look homeless.

New York Judge Paul Engelmayer just forbade all political appointees — including Treasury Secretary Scott Bessent — from accessing Dept. of Treasury data, all based on Blueanon conspiracy theories!! Those theories couldn't be challenged because the order was EX PARTE — meaning Trump's lawyers weren't warned, and couldn't weigh in. Only Democrat Attorneys General were allowed to argue. The judge cites no law or logic to support this unprecedented order, because it defies both. The judge’s ruling is, in essence, that Scott Bessent simply occupies a ceremonial position without real power, like the King of England. This is a grenade thrown into the functioning of the Treasury Department. It forbids the elected government from accessing information about budget and finances. Instead, only the permanent, deep-state government can know what's being spent. It means Scott Bessent's subordinates have far more power than Scott Bessent does. Democrat pundits who whine about the Constitution are liars, and will shred it the first chance they get. For now, the order is only for the next week, but if a court tries to make it permanent the Trump Administration should absolutely consider defying it. Better yet, SCOTUS should bar this judge from ever hearing similar cases again, and every Democrat lawyer involved should be sanctioned.

🚨SCIENTISTS DISCOVER MOLECULAR SWITCH TO REVERSE CANCER Researchers in South Korea have identified a way to turn cancer cells back into healthy ones—potentially revolutionizing treatment. Scientists at KAIST found a “molecular switch” that stops normal cells from becoming cancerous, offering a new path for reversing tumors. By studying the moment of transformation, they created a model to reset cancer cells—successfully restoring normal function in colon cancer trials. Source: Newsweek